Page last updated: 2024-08-24

irinotecan and 4-nitrophenyl acetate

irinotecan has been researched along with 4-nitrophenyl acetate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mazzolari, A; Pedretti, A; Testa, B; Vistoli, G1
Bugat, R; Canal, P; Chatelut, E; Guichard, S; Hennebelle, I; Terret, C1
Band, R; Bowen, D; Cottrell, J; Grem, JL; Guemei, AA; Hehman, H; Ismail, AS; Pavlov, MV; Prudhomme, M; Takimoto, CH; Taylor, RE1
Kim, SR; Kubo, T; Matsumoto, K; Minami, H; Nakajima, T; Ohno, Y; Ohtsu, A; Ozawa, S; Sai, K; Saijo, N; Saito, H; Saito, Y; Sawada, J; Shirao, K; Yamamoto, N; Yoshida, T1
Furukubo, T; Hojo, A; Izumi, S; Katsube, Y; Koide, H; Minegaki, T; Nishiguchi, K; Ochiai, M; Shima, D; Tsujimoto, M; Yamakawa, T1

Trials

1 trial(s) available for irinotecan and 4-nitrophenyl acetate

ArticleYear
Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan.
    Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Area Under Curve; Butyrylcholinesterase; Butyrylthiocholine; Camptothecin; Carboxylic Ester Hydrolases; Humans; Hydrolysis; Irinotecan; Nitrophenols; Predictive Value of Tests

2001

Other Studies

4 other study(ies) available for irinotecan and 4-nitrophenyl acetate

ArticleYear
In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations.
    Bioorganic & medicinal chemistry, 2010, Jan-01, Volume: 18, Issue:1

    Topics: Carboxylic Ester Hydrolases; Catalytic Domain; Computer Simulation; Humans; Hydrophobic and Hydrophilic Interactions; Molecular Dynamics Simulation; Protein Binding; Protein Conformation; Substrate Specificity

2010
Characterization of CPT-11 converting carboxylesterase activity in colon tumor and normal tissues: comparison with p-nitro-phenylacetate converting carboxylesterase activity.
    Anti-cancer drugs, 2000, Volume: 11, Issue:6

    Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carboxylic Ester Hydrolases; Colon; Colonic Neoplasms; DNA Topoisomerases, Type I; Enzyme Activation; Enzyme Inhibitors; Humans; Irinotecan; Kinetics; Liver; Nitrophenols; Rats; Substrate Specificity; Topoisomerase I Inhibitors

2000
Functional characterization of three naturally occurring single nucleotide polymorphisms in the CES2 gene encoding carboxylesterase 2 (HCE-2).
    Drug metabolism and disposition: the biological fate of chemicals, 2005, Volume: 33, Issue:10

    Topics: Animals; Asian People; Camptothecin; Carboxylesterase; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Humans; Irinotecan; Nitrophenols; Polymorphism, Single Nucleotide; RNA Splicing; Umbelliferones

2005
Acceleration of carboxylesterase-mediated activation of irinotecan to SN-38 by serum from patients with end-stage kidney disease.
    Cancer chemotherapy and pharmacology, 2018, Volume: 81, Issue:6

    Topics: Carboxylesterase; Case-Control Studies; Fatty Acids; Humans; Irinotecan; Kidney Failure, Chronic; Microsomes, Liver; Nitrophenols; Topoisomerase I Inhibitors; Uremia

2018